Loading clinical trials...

Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease | Clinical Trials | Clareo Health

RECRUITING

Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease

NCT06924359•Peking University First Hospital

View on ClinicalTrials.gov

Summary

With the accelerating global aging population, dementia has become a pressing worldwide issue. This project aims to identify specific plasma biomarkers and ocular indicators for the early detection of Alzheimer's disease (AD).

Eligibility

Age

50 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Male or female participants aged ≥ 50 years;
•Participants diagnosed with Alzheimer's Disease (AD), mild cognitive decline (MCI), subjective cognitive decline (SCD), or cognitively normal (CN);
•Signed informed consent form

Exclusion Criteria

•Presence of other neurological disorders and systemic diseases that may cause cognitive impairment;
•Inability to cooperate with cognitive assessments;
•Refusal to undergo blood sampling.

Locations (1)

Peking University First Hospital

Beijing, China

Key Dates

Start Date

March 19, 2025

Primary Completion Date

August 31, 2027

Completion Date

August 31, 2027

Last Updated

April 11, 2025

Enrollment

200

ESTIMATED participants

Conditions

Alzheimer's Disease (AD)

Interventions

Multimodal Ophthalmic Imaging and plasma biomarker

DIAGNOSTIC_TEST

Impact of Ketoflex 12/3 Diet on Early-to-Mid Stage Alzheimer's Progression

NCT06898424

Alzheimer Type DementiaAlzheimer's Disease (AD)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 11, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions